Evidence map›Paper›PMID 34106570›Full record

ArticleMicrobiology spectrum2021

Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model.

Victor Garcia-Bustos, Amparo Ruiz-Saurí, Alba Ruiz-Gaitán, Ignacio Antonio Sigona-Giangreco, Marta Dafne Cabañero-Navalon, Oihana Sabalza-Baztán, Miguel Salavert-Lletí, María Ángeles Tormo, Javier Pemán

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Article
  3. Clinical Outcomes ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  4. Article
  5. The Joint Action of Bacteriophage and Antibiotics in the Treatment ofbioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Microbiology spectrum · 2026
    Article
  8. Adaptive microevolution in CC17Frontiers in cellular and infection microbiology · 2026
    Article
  9. Frontiers in pharmacology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. The dynamics ofmSphere · 2025
    Article
  14. Article
  15. The Dynamics ofbioRxiv : the preprint server for biology · 2025
    Article
  16. Microbiology spectrum · 2025
    Article
  17. Journal of fungi (Basel, Switzerland) · 2025
    Review
  18. Interactions of the emerging fungusMicrobiology spectrum · 2025
    Article
  19. Relationships BetweenPathogens (Basel, Switzerland) · 2025
    Article
  20. Innate immune response to Candida auris.Current opinion in microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Victor Garcia-BustosDepartment of Internal Medicine and Infectious Diseases, University and Polytechnic La Fe Hospital, Valencia, Spain.ORCID 0000-0002-1785-258X
Amparo Ruiz-SauríDepartment of Pathology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain.
Alba Ruiz-GaitánSevere Infection Research Group, Health Research Institute La Fe, Valencia, Spain.
Ignacio Antonio Sigona-GiangrecoSevere Infection Research Group, Health Research Institute La Fe, Valencia, Spain.
Marta Dafne Cabañero-NavalonDepartment of Internal Medicine and Infectious Diseases, University and Polytechnic La Fe Hospital, Valencia, Spain.
Oihana Sabalza-BaztánDepartment of Medical Microbiology, University and Polytechnic La Fe Hospital, Valencia, Spain.
Miguel Salavert-LletíDepartment of Internal Medicine and Infectious Diseases, University and Polytechnic La Fe Hospital, Valencia, Spain.
María Ángeles TormoSevere Infection Research Group, Health Research Institute La Fe, Valencia, Spain.
Javier PemánSevere Infection Research Group, Health Research Institute La Fe, Valencia, Spain.ORCID 0000-0003-3222-5653
Hospital Universitari i Politècnic La Fe · ESLeitat Technological Center · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candida auris is an emergent multidrug-resistant fungal pathogen considered a severe global threat due to its capacity to cause nosocomial outbreaks and deep-seated infections with high transmissibility and mortality. However, evidence on its pathogenicity and the complex host-pathogen interactions is still limited. This study used the

Indexed as

AnimalsCandida aurisCandidiasisDisease Models, AnimalLarvaMothsPhenotypeVirulenceCandidaCandida aurisfilamentationpathogenicityvirulence

Identifiers

PMID34106570
PMCPMC8552516
OpenAlexW3168790032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.